The verified answer
As of Oct 2026, DEPLOY verifies MMI (Medical Microinstruments): 1 model, 2 deployments across 2 regions, $211.0M raised. 1 source back the record.
CategorySurgical robots
Overview
Italian-founded surgical robotics company developing the Symani Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.
Reality check
NanoWrist (company-claimed)
World's smallest wristed surgical robotic instruments.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Valuation of record
DEPLOY VERIFIEDPriced roundSeries C post-money
Key facts
CEO
Founded
HQ
Product
FDA (Apr 2024)
CE mark (2019)
Clinical cases
Key investors
REMIND study
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →MMI (Medical Microinstruments) on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Dec 2025. Explore where MMI (Medical Microinstruments)'s robots are operating, by place and type.
View the full MMI (Medical Microinstruments) deployment record →
Relationships
Current leadership (1)
- Mark Toland CEOSEC-verified
Safety record
No incidents on record for MMI (Medical Microinstruments).
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- MMI (Medical Microinstruments)2 deployments
Recent coverage
MMI (Medical Microinstruments) in third-party press
Peers
41 peers across 1 segment. Every MMI (Medical Microinstruments) competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Butterfly Networkdirect competitor(inferred)strong
- Cornerstone Roboticsdirect competitor(inferred)strong
- Edge Medical Roboticsdirect competitor(inferred)strong
- ForSight Roboticsdirect competitor(inferred)strong
- LDR Holding Corporationdirect competitor(inferred)strong
- LEM Surgicaldirect competitor(inferred)strong
Financial state
- Total funding
- $211.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (4)
MMI (Medical Microinstruments)’s 4 disclosed rounds, $211M in total, oldest to newest.
- Series C2024-02-21
$110M · $1.1B post
Investors: Fidelity Management & Research Company (lead), Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital, Sambatech, Wellington Partners
- Series B2022-07-20
$75M · $600M post
Investors: Deerfield Management (lead), RA Capital Management, Biostar Capital, Andera Partners, Fountain Healthcare Partners, Panakès Partners, Sambatech
- Series A2018-01-01
$24M · $144M post
Investors: Andera Partners, Fountain Healthcare Partners, Panakès Partners, Wellington Partners
- Seed2016-01-01
$2M · $8M post
Timeline
Every recorded move in MMI (Medical Microinstruments)’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries C funding round
2024-02-21Series C raising $110000000
Funding roundSeries B funding round
2022-07-20Series B raising $75000000
Funding roundSeries A funding round
2018-01-01Series A raising $24000000
Funding roundSeed funding round
2016-01-01Seed raising $2000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 18, 2026
Added to the verified registry
- Deployment verifiedVerifiedDec 9, 2025
Symani Surgical System at Tampa, FL
- Deployment verifiedVerifiedJul 1, 2021
Symani Surgical System at Florence, Italy
Sources (1)
- MMI · https://mmimicro.com
Common questions
What is MMI (Medical Microinstruments)?
What does MMI (Medical Microinstruments) make?
Is MMI (Medical Microinstruments) publicly traded?
Who competes with MMI (Medical Microinstruments)?
Who is the CEO of MMI (Medical Microinstruments)?
How can I invest in MMI (Medical Microinstruments)?
Where is MMI (Medical Microinstruments) headquartered?
How much funding has MMI (Medical Microinstruments) raised?
Who owns MMI (Medical Microinstruments)?
Where does MMI (Medical Microinstruments) operate robots?
How many robots has MMI (Medical Microinstruments) deployed?
Is MMI (Medical Microinstruments) a top robotics company?
Is MMI (Medical Microinstruments) safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-12
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-12
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for MMI (Medical Microinstruments).Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
In the press
Recent coverage mentioning MMI (Medical Microinstruments) from third-party publications. Automatically surfaced; not part of the verified registry record.
'Putting the body back together' with MMI's microsurgery robot
MedTech Dive profile of MMI's Symani Surgical System and Synaptix digital platform, which can be moved between operating rooms for microsurgical procedures including breast cancer…
MMI Receives FDA Authorization to Commercialize Symani Surgical System in the U.S.
Medical Microinstruments received FDA De Novo authorization to commercialize its Symani Surgical System in the U.S., building on proven clinical success in Europe.
MMI Raises $110 Million in Series C Financing
MMI raised $110M in Series C led by Fidelity Management & Research Company, the largest ever investment in microsurgery innovation. Funds support commercialization of Symani…
Medical Microinstruments collects $110M to fund surgical robot rollout
Medical Microinstruments secured $110M in venture capital funding to support the commercial rollout of its Symani robotic microsurgery system globally.
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
MMI raised $75M in Series B financing led by Deerfield Management with RA Capital and Biostar Capital. Company announced corporate redomicile from Italy to the United States.
Machine-readable surfaces
- Markdown mirror: /companies/mmi-symani.md
- RSS feed: /companies/mmi-symani/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/a0bb956c-fcf2-4374-b893-42388bad22be
- Revision history: /companies/mmi-symani/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
Video
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
MMI (Medical Microinstruments) draws attention at the 24th percentile but verifies reality at the 64th percentile among surgical robots. Hype Gap -40.8, 40th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 17, 2026